FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
2025 · 1st Quarter (Jan 1 - Mar 31)
PARATEK PHARMACEUTICALS
Filed by PARATEK PHARMACEUTICALS.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Mar 13, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- PARATEK PHARMACEUTICALS
- Client
- PARATEK PHARMACEUTICALS
- Filing UUID
- 9614f5e1-e4c1-4a94-878e-160dc7281a5d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.